# Safety and Efficacy of Once-Daily KRP-104 in Type 2 Diabetics With Inadequate Glycemic Control on Metformin Alone

> **NCT00995345** · PHASE2 · COMPLETED · sponsor: **ActivX Biosciences, Inc.** · enrollment: 403 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** KRP-104
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00995345
- **Lead sponsor:** ActivX Biosciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 403 (ACTUAL)
- **Last updated:** 2014-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00995345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00995345, "Safety and Efficacy of Once-Daily KRP-104 in Type 2 Diabetics With Inadequate Glycemic Control on Metformin Alone". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00995345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*